Oncogenic transformation of mesenchymal stem cells decreases Nrf2 expression favoring in vivo tumor growth and poorer survival
about
Cytoprotection "gone astray": Nrf2 and its role in cancerThe redox biology network in cancer pathophysiology and therapeuticsGene expression profiling of ovarian carcinomas and prognostic analysis of outcome.Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients.A Case-Control Study of Involvement of Oxidative DNA Damage and Alteration of Antioxidant Defense System in Patients with Basal Cell Carcinoma: Modulation by Tumor RemovalLysosomal acid lipase in mesenchymal stem cell stimulation of tumor growth and metastasis.Phenethyl isothiocyanate, by virtue of its antioxidant activity, inhibits invasiveness and metastatic potential of breast cancer cells: HIF-1α as a putative target.Down-regulation of lipocalin 2 suppresses the growth of human lung adenocarcinoma through oxidative stress involving Nrf2/HO-1 signaling.Raf/ERK/Nrf2 signaling pathway and MMP-7 expression involvement in the trigonelline-mediated inhibition of hepatocarcinoma cell migration.Epigenetic modifications of triterpenoid ursolic acid in activating Nrf2 and blocking cellular transformation of mouse epidermal cells.Propoxur enhances MMP-2 expression and the corresponding invasion of human breast cancer cells via the ERK/Nrf2 signaling pathway.IFN-gamma priming of adipose-derived stromal cells at "physiological" hypoxia.The Roles of 4β-Hydroxywithanolide E from Physalis peruviana on the Nrf2-Anti-Oxidant System and the Cell Cycle in Breast Cancer Cells.Mesenchymal stem cell in vitro labeling by hybrid fluorescent magnetic polymeric particles for application in cell tracking.Understanding life and death decisions in human leukaemias.
P2860
Q28393784-B0CB3354-1DFE-43FA-848C-A1EAEEA88570Q35849711-432985CD-B0F4-41ED-9826-32AB40900A8EQ35906593-4462449B-DD49-4160-A5A6-E7BB5BCBD244Q36172096-20A6568B-DBE7-4960-8298-CB0BD819A672Q36537212-71C9A05A-8FF0-4BC9-A6F8-65700A213590Q37641570-FDAA7DBD-1C92-473B-A546-9850218C4A06Q38826788-FE53ACC1-FCD4-4F13-8A8A-C6DC24E66F54Q38836884-1C782F29-BD38-42F5-AB52-C56B6663CC65Q39135443-30D42D04-8760-4802-88E0-722EF1E19160Q41843735-DCB3F806-CC28-4871-9BF1-ADB73B8F4D72Q45904707-20603C5B-DD89-4AAA-960D-A8F9F43AD927Q46353234-E914FB1E-BCE6-4868-9EC0-4659AC663EFEQ46558958-98064690-9258-4F22-A55E-905AD87CAE22Q48673712-4B1FA906-ABDA-47E0-BBAA-A10826B740A9Q55071953-E23985B5-ED94-4332-A164-9DA5347D5CBC
P2860
Oncogenic transformation of mesenchymal stem cells decreases Nrf2 expression favoring in vivo tumor growth and poorer survival
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Oncogenic transformation of me ...... mor growth and poorer survival
@ast
Oncogenic transformation of me ...... mor growth and poorer survival
@en
Oncogenic transformation of me ...... or growth and poorer survival.
@nl
type
label
Oncogenic transformation of me ...... mor growth and poorer survival
@ast
Oncogenic transformation of me ...... mor growth and poorer survival
@en
Oncogenic transformation of me ...... or growth and poorer survival.
@nl
prefLabel
Oncogenic transformation of me ...... mor growth and poorer survival
@ast
Oncogenic transformation of me ...... mor growth and poorer survival
@en
Oncogenic transformation of me ...... or growth and poorer survival.
@nl
P2093
P2860
P356
P1433
P1476
Oncogenic transformation of me ...... mor growth and poorer survival
@en
P2093
Barbara Pedley
Chris Boshoff
James M Flanagan
Juan M Funes
Mathew Robson
Rachel Kaufman
Salvador Moncada
P2860
P2888
P356
10.1186/1476-4598-13-20
P577
2014-02-03T00:00:00Z
P5875
P6179
1006631484